Torrent Pharmaceuticals Limited
Listed as TORNTPHARM: its shares held by funds are on the stock page.
% of scheme: the share of the scheme's net assets, as the fund house states it. Sep 2026: "—" = no Sep 2026 portfolio from that fund house.
| Security | Grade or sector, as printed | Held | Schemes |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. (22/12/2026) ** Commercial paper · INE685A14187 | ICRA A1+ / IND A1+ / [ICRA]A1+ / CRISIL A1+ | ₹1,123 cr | 5 |
| 7.45% Torrent Pharmaceuticals Limited (19/01/2028) ** Bond / debenture · INE685A07132 | ICRA AA+ / [ICRA]AA+ / ICRA-AA+ | ₹1,022 cr | 16 |
| NCD TORRENT PHARMACEUTICALS LTD. Bond / debenture · INE685A07157 | ICRA AA+ / [ICRA]AA+ / ICRA-AA+ | ₹489 cr | 18 |
| Torrent Pharmaceuticals Limited** Bond / debenture · INE685A07173 | ICRA AA+ / ICRA-AA+ | ₹236 cr | 4 |
| TORRENT PHARMACEUTICALS LTD.** Bond / debenture · INE685A07165 | ICRA AA+ / ICRA-AA+ | ₹85.8 cr | 5 |
Name, and the credit agency grade (or a sector, where the fund house prints one), as the fund houses print them: several spellings, the most common; several grades, all of them, most common first. This site gives no view on credit.
| Month | Held | Schemes | Fund houses holding / covered |
|---|---|---|---|
| Oct 2026 | ₹2,956 cr | 39 | 13 / 38 |
| Sep 2026 | ₹2,906 cr | 40 | 13 / 38 |
| Aug 2026 | ₹2,775 cr | 38 | 12 / 37 |
| Jul 2026 | ₹2,776 cr | 39 | 13 / 39 |
| Jun 2026 | ₹2,858 cr | 39 | 12 / 38 |
| May 2026 | ₹2,815 cr | 39 | 12 / 39 |
| Apr 2026 | ₹2,640 cr | 39 | 12 / 39 |
| Mar 2026 | ₹2,590 cr | 34 | 9 / 39 |
| Feb 2026 | ₹2,645 cr | 37 | 9 / 42 |
| Jan 2026 | ₹2,736 cr | 32 | 7 / 41 |
A month with fewer fund houses covered is not comparable in full with one with more. Bonds, debentures, commercial paper, certificates of deposit, securitised debt and preference shares a company, bank or trust issued, as each fund house lists them in its monthly portfolio. Government securities, REIT/InvIT units and fund units are not included. Credit agency grades are copied as the fund house prints them; this site gives no view on credit. Not investment advice.